We are live on ! Find out more
RCPI

Rock Creek Pharmaceuticals
RCPI

Delisted

RCPI was delisted on the 4th of November, 2015.

36 hedge funds and large institutions have $1.73M invested in Rock Creek Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

245% more capital inflows, than outflows

Capital inflows: $1.24M | Capital outflows: $358K

91% more call options, than puts

Call options by funds: $193K | Put options by funds: $101K

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

39% less funds holding

Funds holding: 59 → 36 (-23)

79% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 29

Holders
36
Holders Change
-23
Holders Change %
-38.98%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
7
Closed
29
Calls
$193​K
Puts
$101​K
Net Calls
+$92​K
Net Calls Change
+$96​K

RCPI Hedge Fund Activity: Q2 2015 in Review

36 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Rock Creek Pharmaceuticals (RCPI) for Q2 2015, worth a combined $1.73M — down 11% from $1.95M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of RCPI and 6 opened new positions — a net loss of 23 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Tenor Capital Management, opening a new position worth an estimated $443K. The largest seller was Geode Capital Management, exiting entirely with an estimated $80K sold.

  • 36 institutional investors held Rock Creek Pharmaceuticals (RCPI) as of Q2 2015, down from 59 in Q1 2015.
  • Funds reported $1.73M of Rock Creek Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
  • 6 funds opened new Rock Creek Pharmaceuticals positions in Q2 2015 and 29 closed out, a net change of -23 holders.
  • The largest Rock Creek Pharmaceuticals buyer in Q2 2015 was Tenor Capital Management, an estimated $443K added.
  • The largest Rock Creek Pharmaceuticals seller in Q2 2015 was Geode Capital Management, an estimated $80K sold.

Based on aggregated 13F filings for Q2 2015.